BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 18751390)

  • 1. Aberrant methylation of p16, DLEC1, BLU and E-cadherin gene promoters in nasopharyngeal carcinoma biopsies from Tunisian patients.
    Ayadi W; Karray-Hakim H; Khabir A; Feki L; Charfi S; Boudawara T; Ghorbel A; Daoud J; Frikha M; Busson P; Hammami A
    Anticancer Res; 2008; 28(4B):2161-7. PubMed ID: 18751390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of E-cadherin and beta-catenin with metastasis in nasopharyngeal carcinoma.
    Li Z; Ren Y; Lin SX; Liang YJ; Liang HZ
    Chin Med J (Engl); 2004 Aug; 117(8):1232-9. PubMed ID: 15361301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patterns of aberrant DNA hypermethylation in nasopharyngeal carcinoma in Tunisian patients.
    Challouf S; Ziadi S; Zaghdoudi R; Ksiaa F; Ben Gacem R; Trimeche M
    Clin Chim Acta; 2012 Apr; 413(7-8):795-802. PubMed ID: 22296674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patterns of gene promoter methylation in squamous cell cancer of the head and neck.
    Hasegawa M; Nelson HH; Peters E; Ringstrom E; Posner M; Kelsey KT
    Oncogene; 2002 Jun; 21(27):4231-6. PubMed ID: 12082610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Promoter hypermethylation of multiple genes in nasopharyngeal carcinoma.
    Kwong J; Lo KW; To KF; Teo PM; Johnson PJ; Huang DP
    Clin Cancer Res; 2002 Jan; 8(1):131-7. PubMed ID: 11801549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aberrant methylation of E-cadherin and H-cadherin genes in nonsmall cell lung cancer and its relation to clinicopathologic features.
    Kim DS; Kim MJ; Lee JY; Kim YZ; Kim EJ; Park JY
    Cancer; 2007 Dec; 110(12):2785-92. PubMed ID: 17960794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypermethylation of epithelial-cadherin gene promoter is associated with Epstein-Barr virus in nasopharyngeal carcinoma.
    Niemhom S; Kitazawa S; Kitazawa R; Maeda S; Leopairat J
    Cancer Detect Prev; 2008; 32(2):127-34. PubMed ID: 18632221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor-specific methylation in bronchial lavage for the early detection of non-small-cell lung cancer.
    Kim H; Kwon YM; Kim JS; Lee H; Park JH; Shim YM; Han J; Park J; Kim DH
    J Clin Oncol; 2004 Jun; 22(12):2363-70. PubMed ID: 15197197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Promoter hypermethylation profile of ovarian epithelial neoplasms.
    Makarla PB; Saboorian MH; Ashfaq R; Toyooka KO; Toyooka S; Minna JD; Gazdar AF; Schorge JO
    Clin Cancer Res; 2005 Aug; 11(15):5365-9. PubMed ID: 16061849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Detection of free tumor-related DNA in the serum of breast cancer patients].
    Zhang JJ; Ouyang T; Wan WH; Deng GR
    Zhonghua Zhong Liu Za Zhi; 2007 Aug; 29(8):609-13. PubMed ID: 18210882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Analysis of suppressive roles of BLU gene at 3p21.3 in nasopharyngeal carcinoma].
    Liu XQ; Pan ZG; Li MZ; Jiang JH; Fu J; Long QX; Wang XZ; Zeng YX
    Ai Zheng; 2003 Feb; 22(2):128-35. PubMed ID: 12600284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Promoter hypermethylation of RASSF1A and RUNX3 genes as an independent prognostic prediction marker in surgically resected non-small cell lung cancers.
    Yanagawa N; Tamura G; Oizumi H; Kanauchi N; Endoh M; Sadahiro M; Motoyama T
    Lung Cancer; 2007 Oct; 58(1):131-8. PubMed ID: 17606310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of a multiple epigenetic marker panel for lung cancer detection and risk assessment in plasma.
    Hsu HS; Chen TP; Hung CH; Wen CK; Lin RK; Lee HC; Wang YC
    Cancer; 2007 Nov; 110(9):2019-26. PubMed ID: 17876837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mapping the methylation pattern by bisulfite genomic sequencing of the E-cadherin promoter CpG island in nasopharyngeal carcinoma.
    Kao RH; Huang LC; Hsu YH
    Anticancer Res; 2002; 22(6C):4109-13. PubMed ID: 12553040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analyses of promoter hypermethylation for RUNX3 and other tumor suppressor genes in nasopharyngeal carcinoma.
    Tan SH; Ida H; Goh BC; Hsieh W; Loh M; Ito Y
    Anticancer Res; 2006; 26(6B):4287-92. PubMed ID: 17201146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Influence of E-cadherin promoter methylation and mutation of beta-catenin on invasion and metastasis of nasopharyngeal carcinoma cells].
    Li Z; Lin SX; Liang YJ
    Zhonghua Zhong Liu Za Zhi; 2003 May; 25(3):238-42. PubMed ID: 12839684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic inactivation of the candidate 3p21.3 suppressor gene BLU in human cancers.
    Agathanggelou A; Dallol A; Zöchbauer-Müller S; Morrissey C; Honorio S; Hesson L; Martinsson T; Fong KM; Kuo MJ; Yuen PW; Maher ER; Minna JD; Latif F
    Oncogene; 2003 Mar; 22(10):1580-8. PubMed ID: 12629521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hypermethylation status of blu gene in nasopharyngeal lymphoma].
    Zhang XH; Jiang F; Li M; Xu Q; Li N; Tao Q; Gao ZF
    Zhonghua Xue Ye Xue Za Zhi; 2003 Mar; 24(3):138-40. PubMed ID: 12697125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Promoter CpG methylation of tumor suppressor genes in colorectal cancer and its relationship to clinical features.
    Lin SY; Yeh KT; Chen WT; Chen HC; Chen ST; Chiou HY; Chang JG
    Oncol Rep; 2004 Feb; 11(2):341-8. PubMed ID: 14719065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetic changes in tumor suppressor genes, P15, P16, APC-3 and E-cadherin in body fluid.
    Chen ML; Chang JH; Yeh KT; Chang YS; Chang JG
    Kaohsiung J Med Sci; 2007 Oct; 23(10):498-503. PubMed ID: 18055295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.